Details

Autor(en) / Beteiligte

• Wormser, Gary P.
• Brady, Kathryn C.
• Cho, Michelle S.
• Scavarda, Carol A.
• McKenna, Donna

Titel

Efficacy of a 14-day course of amoxicillin for patients with erythema migrans

Ist Teil von

• Diagnostic microbiology and infectious disease, 2019-06, Vol.94 (2), p.192-194

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2019

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Although a 14-day treatment course with amoxicillin is in wide clinical usage to treat early Lyme disease, only a few published studies exist to validate its efficacy and safety, with none in the United States. In this study, we reviewed the records of 24 prospectively followed adult patients with erythema migrans who were prescribed a 14-day course of amoxicillin, 500 mg 3 times daily. Treatment with amoxicillin was well tolerated and uniformly successful in resolving the erythema migrans skin lesion and in preventing the development of an objective neurologic, cardiac, or rheumatologic manifestation. Although the study was relatively small and only involved a single center, the findings provide additional evidence that a 14-day course of 500 mg amoxicillin given 3 times per day is highly effective therapy for patients with early Lyme disease. •A 14-day course of amoxicillin is often used to treat early Lyme disease.•No clinical study in the United States, however, has validated this drug regimen.•Twenty-four adult patients with erythema migrans were treated with amoxicillin.•A 14-day course of amoxicillin was highly effective and well tolerated.